drugset / Trial / NCT04076943

Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia

NCT04076943

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out if roxadustat (also known as FG-4592) is safe and effective for the treatment of anemia in participants receiving chemotherapy treatment for cancer.

Timeline

Start
2019-08-20
Primary completion
2021-03-26
Completion
2021-04-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Roxadustat Small molecule Oral